Literature DB >> 26045803

Bone morphogenetic protein is required for fibroblast growth factor 2-dependent later-stage osteoblastic differentiation in cranial suture cells.

Taoran Jiang1, Shengfang Ge2, Yoong Hoon Shim1, Ce Zhang1, Dejun Cao1.   

Abstract

BACKGROUND: Understanding the pathophysiological process of calvarial bones development is important for the treatments on relative diseases such as craniosynostosis. While, the role of fibroblast growth factor (FGF) and bone morphogenetic protein (BMP) and how they interacted in osteoblast differentiation remain unclear.
METHODS: we digested bone fragments around the coronal and sagittal sutures from newborn rats to harvest suture cells. Markers expression at different osteoblast differentiation stage was analyzed by increasing FGF2 concentration and BMP2 blocking in these cells.
RESULTS: BMP2 expression could be stimulated by FGF2 in a dose and time dependent manner. FGF2 stimulation may decrease early marker of osteoblast differentiation (collagen type-1, COL-1) and increase the expression of continuously-expressed or late markers (alkaline phosphatase, ALP; osteocalcin, OC and bone sialoprotein, BSP) to accelerate mineralization. Inhibition of BMP2 signaling by Noggin weakens the effect of FGF2 on induction of later-stage osteoblastic differentiation of cranial suture cells.
CONCLUSION: Our data suggest that BMP2 signaling is required for FGF2-dependent induction of later-stage of cranial suture cell osteoblastic differentiation.

Entities:  

Keywords:  Fibroblast growth factor 2 (FGF2); bone morphogenetic protein 2 (BMP2); osteoblast differentiation; suture cells

Mesh:

Substances:

Year:  2015        PMID: 26045803      PMCID: PMC4440112     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  28 in total

1.  A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome.

Authors:  M Muenke; K W Gripp; D M McDonald-McGinn; K Gaudenz; L A Whitaker; S P Bartlett; R I Markowitz; N H Robin; N Nwokoro; J J Mulvihill; H W Losken; J B Mulliken; A E Guttmacher; R S Wilroy; L A Clarke; G Hollway; L C Adès; E A Haan; J C Mulley; M M Cohen; G A Bellus; C A Francomano; D M Moloney; S A Wall; A O Wilkie
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

Review 2.  Craniosynostosis: genes and mechanisms.

Authors:  A O Wilkie
Journal:  Hum Mol Genet       Date:  1997       Impact factor: 6.150

3.  The molecular basis of Boston-type craniosynostosis: the Pro148-->His mutation in the N-terminal arm of the MSX2 homeodomain stabilizes DNA binding without altering nucleotide sequence preferences.

Authors:  L Ma; S Golden; L Wu; R Maxson
Journal:  Hum Mol Genet       Date:  1996-12       Impact factor: 6.150

4.  Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro.

Authors:  L A Opperman; R W Passarelli; E P Morgan; M Reintjes; R C Ogle
Journal:  J Bone Miner Res       Date:  1995-12       Impact factor: 6.741

5.  Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts.

Authors:  D Chen; M A Harris; G Rossini; C R Dunstan; S L Dallas; J Q Feng; G R Mundy; S E Harris
Journal:  Calcif Tissue Int       Date:  1997-03       Impact factor: 4.333

6.  The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4.

Authors:  L B Zimmerman; J M De Jesús-Escobar; R M Harland
Journal:  Cell       Date:  1996-08-23       Impact factor: 41.582

Review 7.  Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling.

Authors:  P J Marie; F Debiais; E Haÿ
Journal:  Histol Histopathol       Date:  2002       Impact factor: 2.303

8.  A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis.

Authors:  E W Jabs; U Müller; X Li; L Ma; W Luo; I S Haworth; I Klisak; R Sparkes; M L Warman; J B Mulliken
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

9.  Novel regulators of bone formation: molecular clones and activities.

Authors:  J M Wozney; V Rosen; A J Celeste; L M Mitsock; M J Whitters; R W Kriz; R M Hewick; E A Wang
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

10.  Fibroblast growth factor 2 induces increased calvarial osteoblast proliferation and cranial suture fusion.

Authors:  Amr M Moursi; Phillip L Winnard; Alissa V Winnard; John M Rubenstrunk; Mark P Mooney
Journal:  Cleft Palate Craniofac J       Date:  2002-09
View more
  8 in total

1.  Neohesperidin promotes the osteogenic differentiation of human bone marrow stromal cells by inhibiting the histone modifications of lncRNA SNHG1.

Authors:  Chuanxin Zhang; Shuai Yuan; Yi Chen; Bo Wang
Journal:  Cell Cycle       Date:  2021-08-30       Impact factor: 5.173

2.  Isolation and Characterization of Human Suture Mesenchymal Stem Cells In Vitro.

Authors:  Liangliang Kong; Yuan Wang; Yi Ji; Jianbing Chen; Jie Cui; Weimin Shen
Journal:  Int J Stem Cells       Date:  2020-11-30       Impact factor: 2.500

3.  Associations between microRNA binding site SNPs in FGFs and FGFRs and the risk of non-syndromic orofacial cleft.

Authors:  Dandan Li; Hongchuang Zhang; Lan Ma; Yue Han; Min Xu; Zhendong Wang; Hongbing Jiang; Weibing Zhang; Lin Wang; Yongchu Pan
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379

4.  Surface thermal oxidation on titanium implants to enhance osteogenic activity and in vivo osseointegration.

Authors:  Guifang Wang; Jinhua Li; Kaige Lv; Wenjie Zhang; Xun Ding; Guangzheng Yang; Xuanyong Liu; Xinquan Jiang
Journal:  Sci Rep       Date:  2016-08-22       Impact factor: 4.379

Review 5.  TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease.

Authors:  Mengrui Wu; Guiqian Chen; Yi-Ping Li
Journal:  Bone Res       Date:  2016-04-26       Impact factor: 13.567

6.  Craniofacial abnormality with skeletal dysplasia in mice lacking chondroitin sulfate N-acetylgalactosaminyltransferase-1.

Authors:  Hiroko Ida-Yonemochi; Wataru Morita; Nobuo Sugiura; Ryosuke Kawakami; Yuki Morioka; Yuka Takeuchi; Toshiya Sato; Shunichi Shibata; Hideto Watanabe; Takeshi Imamura; Michihiro Igarashi; Hayato Ohshima; Kosei Takeuchi
Journal:  Sci Rep       Date:  2018-11-20       Impact factor: 4.379

Review 7.  Unraveling the Connection between Fibroblast Growth Factor and Bone Morphogenetic Protein Signaling.

Authors:  Anna Schliermann; Joachim Nickel
Journal:  Int J Mol Sci       Date:  2018-10-18       Impact factor: 5.923

Review 8.  Epidrugs: novel epigenetic regulators that open a new window for targeting osteoblast differentiation.

Authors:  Mahsa Ghorbaninejad; Maliheh Khademi-Shirvan; Samaneh Hosseini; Mohamadreza Baghaban Eslaminejad
Journal:  Stem Cell Res Ther       Date:  2020-10-28       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.